Menveo vaccine VL 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FAUGY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $77,277
Award facts
- Contract value 100% obligated
- $77,277.05 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $77,277.05 delivery order to Amerisourcebergen Drug Corp on January 26, 2026, for Menveo vaccine (VL 5S formulation), with an ultimate completion date of February 23, 2026.
The order is issued under Amerisourcebergen's Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999 through December 2026, which supplies pharmaceutical products and medical commodities globally to support military healthcare programs. Place of performance is Conshohocken, PA. The order carries firm fixed pricing with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FAUGY?
SPE2DR26FAUGY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FAUGY worth?
The government has obligated $77,277 on SPE2DR26FAUGY.
Is contract SPE2DR26FAUGY an order under another contract?
Yes. SPE2DR26FAUGY is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAUGY competed?
The extent of competition for SPE2DR26FAUGY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award